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Hepatitis E virus (HEV) is a common cause of acute hep-
atitis worldwide. In Europe, HEV is a zoonosis trans-
mitted via contaminated pork meat or other pork food 
products. Genotype 3 is the most prevalent HEV type 
in the animal reservoir, as well as in humans. Despite 
an increased incidence of hepatitis E across Europe, 
much remains unknown about its spread, sources and 
transmission routes. A One Health approach is crucial 
to better understand the (molecular) epidemiology of 
HEV. HEVnet was established in April 2017 as a net-
work and database for sharing sequences and accom-
panying metadata collected from human, animal, food 
and environmental sources. HEVnet members working 
in the public health, veterinary health, food, environ-
mental and blood safety sectors have submitted 1,615 
HEV sequences from nine countries as at January 2019. 
Most are from humans (89%), and sequences of ani-
mal (5%), food (6%) or environmental (0.3%) origin are 
rare. Metadata for human sequences capture mostly 
sex (93%), year of birth (92%) and sampling (100%); 
data on region of sampling (37%) and clinical infor-
mation (hospitalisation 27%, symptoms 20% or mor-
tality 8%) are limited. HEVnet aims to expand into a 
global network capable of performing cross-sectoral 
and supranational studies, with a joint repository of 
molecular and epidemiological data on HEV.
Introduction
Hepatitis E virus (HEV) is one of the most com-
mon causative agents of acute hepatitis worldwide, 
with four major genotypes (1–4) affecting humans. 
Genotypes 1 and 2 are endemic in tropical and sub-
tropical regions of Africa and Asia, where hepatitis 
E is a waterborne disease associated with sporadic 
cases and large outbreaks via faecal-oral transmission 
or contaminated water. HEV1 and HEV2 infections in 
Europe and the United States (US) are travel associ-
ated [1]. In Europe, hepatitis E is considered a zoonosis 
transmitted via contaminated pork meat or other pork 
food products. Genotype 3 and, to a lesser degree, 
genotype 4 are prevalent in the animal reservoir (pigs, 
wild boar and deer), as well as in humans [2]. There are 
occasional reports of HEV transmission through other 
routes, such as shellfish, salad or vegetables con-
taminated by sewage water carrying HEV from infected 
animals or humans [2-7]. Infection through contami-
nated blood products or other substances of human 
origin have been reported, and some European coun-
tries (the United Kingdom, followed by Ireland and the 
Netherlands) have implemented comprehensive testing 
of blood donations to reduce infections among patients 
who are vulnerable to developing chronic hepatitis E 
[8]. However, food appears to be the main transmission 
route in Europe.
A One Health approach is necessary to understand 
and mitigate HEV transmission via substances of 
human origin, animals, food and the environment [2]. 
Collaboration across disciplines is also crucial for the 
implementation of prevention and control measures 
that benefit public health, as HEV does not cause dis-
ease in animals and is therefore not considered a rel-
evant veterinary issue requiring animal disease-control 
measures [9,10].
According to hepatitis E-specific surveillance systems 
in 20 European Union (EU)/European Economic Area 
(EEA) countries, more than 20,000 cases were reported 
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between 2005–15, of which most were autochthonous 
[8,11]; more than 50% of the cases with known clinical 
information were reported from hospital settings and 
five countries reported a total of 28 fatal cases related 
to a HEV infection during this period [8]. Based on these 
reports, the European Centre for Disease Prevention 
and Control (ECDC) identified a need to support activi-
ties related to the investigation and assessment of HEV 
in the EU/EEA.
During the first ECDC HEV expert meeting in December 
2015—attended by nominated scientists working on 
HEV-related topics in the EU/EEA, the World Health 
Organization (WHO) and the European Food Safety 
Agency (EFSA)—the development of a joint database 
of HEV sequences with metadata to support molecular 
epidemiological investigations was set as a priority, 
as molecular sequences provide more discriminatory 
power than only genotypes and subtypes of the virus 
[8,12]. The subsequent year, the ECDC and its HEV 
expert group further developed the concept of the 
database in collaboration with The National Institute 
for Public Health and the Environment (RIVM). RIVM 
already hosted pathogen-specific online databases 
such as HAVnet (for hepatitis A viruses) and NoroNet 
(for noroviruses), which are tools that have supported 
international investigations of outbreaks and molecu-
lar trends through standardisation and sharing of pro-
tocols [13-15].
This manuscript aims to introduce HEVnet (http://www.
hevnet.nl), an international, cross-disciplinary data-
base of HEV sequence data retrieved from different 
sources (humans, animals, the environment and food) 
and accompanied by relevant metadata for analysing 
the molecular epidemiological relationships between 
circulating HEV strains.
Table 1
Overview of data and experts required to reach the objectives of HEVnet
Requirements
1. Distribution 
and trends 
of circulating 
human HEV 
subtypesa
2. Molecular 
epidemiologyb
3. Cluster 
investigationc
4. 
Relationship 
of viruses 
for source 
attributiond
5. Virus 
evolution 
and 
spreade
6. Clinical 
virology: 
severity of 
viral (sub)
typesf
Data
Human origin sequences and 
typing results according to 
standardised nomenclature, 
with information on time and 
place
Y Y Y Y Y Y
Animal/food/environmental 
origin sequences and 
typing results according to 
standardised nomenclature, 
with time and place
N N N Y Y N
Sequences of an agreed 
genomic region: minimum 
length of 300 nt within ORF2
N Y Y Y Y Y
Standardised metadata: 
demographic and 
epidemiological
N Y Y Y N N
Standardised metadata: clinical 
data N N N N N Y
Timely reporting N N Y Y N N
Expertise
Public health epidemiologists or 
bioinformaticians Y Y Y Y Y Y
Clinical virologists N Y Y Y Y Y
Food/veterinary/environmental 
virologists N N N Y Y N
Physicians N N Y N N Y
HEV: hepatitis E virus.
a Objective 1: to use molecular typing to assess the distribution and trends of HEV genotypes and subtypes circulating in humans.
b Objective 2: to analyse the distribution of subtypes in humans, leading to a better understanding of the underlying epidemiology of HEV.
c Objective 3: to combine human sequences with provided metadata of human cases, for cluster investigation.
d Objective 4: to trace the most likely reservoirs and sources of HEV by identifying connections between human and non-human (food, animal 
and environmental) samples via source attribution studies.
e Objective 5: to do population genetics studies into the spread and evolution of HEV.
f Objective 6: to assess the pathogenicity of strains through assessment of relationships between viral subtypes and severity of disease, 
looking at symptoms, hospitalisation and mortality.
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The HEVnet database
The HEVnet database is a password-protected online 
environment for sharing and analysing HEV sequence 
data accompanied by metadata. The metadata pro-
vide information on the specimen origin (country of 
sampling, date, type), sample origin (human, food, 
environmental or animal), patient (sex, year of birth, 
symptoms, hospitalisation, underlying conditions, 
etc.), behavioural exposure (food worker, animal con-
tact, wastewater contact, other) and clinical param-
eters such as organ transplant or blood transfusion. All 
data are anonymised to ensure that the original source 
of the sample (e.g. an individual) cannot be traced, as 
this type of data is subject to the European General 
Data Protection Regulation [16]. Upon uploading, all 
sequences are automatically typed by a publicly avail-
able, curated, phylogenetic typing tool (https://www.
rivm.nl/mpf/typingtool/hev) in order to secure stand-
ardised genotype and subtype assignment using the 
full-length sequences of reference viruses for HEV typ-
ing and subtyping proposed by Smith et al. in 2016 
[17,18], supplemented with representatives of tentative 
new subtypes.
Data can be queried, analysed and visualised as pie 
charts, geographical maps and phylogenetic trees, 
using a set of analysis modules within the protected 
online working space. Members can retrieve whole 
sequences or a queried selection of the sequences 
in FastA format for phylogenetic analyses. The meta-
data, with a link to the sequences, can be downloaded 
in Excel format for data analyses. The combination of 
phylogenetic and epidemiological data enables viro-
logical, epidemiological or combined investigations.
HEVnet network
The HEVnet network consists of HEV experts, such as 
virologists or epidemiologists in the public health, vet-
erinary health, food, environmental and blood safety 
sectors. Participation in HEVnet is voluntary. A data 
confidentiality agreement grants membership and use 
of the database. Members are expected to respect a 
‘quid pro quo’ principle in using the HEVnet data. The 
complete dataset is available to HEVnet members, 
and data ownership remains with the data provider. 
Compliant with the GDPR, and to promote research 
benefiting public health, all sequence data with a 
restricted set of associated metadata become publicly 
available at a time specified by the data provider, but 
no later than 18 months after submission.
HEVnet objectives
At the first HEVnet meeting in October 2017, 16 network 
members, RIVM’s HEVnet team and representatives of 
ECDC and EFSA agreed that the objectives of HEVnet 
are to use molecular typing to assess trends in circulat-
ing HEV genotypes and subtypes in humans at an inter-
national level and to analyse the distribution of HEV 
subtypes in humans for better understanding of the 
epidemiology (e.g. characteristics) of the affected pop-
ulations and the geographical relationships between 
viruses. Furthermore, HEVnet supports the investiga-
tion of clusters across countries. The pooled analysis 
of sequences across disciplines generates evidence 
about the relationships between isolates from human, 
animal, food and environmental specimens, and may 
help to identify sources of infection and transmission 
routes. Increased availability of sequence informa-
tion should enable more in-depth virological analysis 
to study viral evolution. Linking of case-based patient 
data with molecular information could also support 
clinical studies on the pathogenicity and severity of 
viral types and subtypes, as well as the association of 
genotypes and clinical manifestations.
Table 1  outlines the objectives of HEVnet, as well as 
the data requirements and expertise needed to meet 
these objectives, such as standardisation of the gen-
erating and reporting of sequence data. As a first 
step, the HEVnet members agreed that a minimum 
sequence length of 300 nt within ORF2 is required for 
robust analyses of HEV. Further, results relevant to risk 
assessments or clinicians will be communicated to the 
respective stakeholders, e.g. EFSA and ECDC.
Current and future uses of the HEVnet 
database
Since the system was launched in April 2017, 41 individ-
ual accounts have been created in HEVnet for experts 
from 15 countries: Austria, Belgium, Denmark, England 
Table 2
Overview of metadata reported for 1,615 sequences 
submitted to HEVnet, April 2017–January 2019
Metadata with sequences N
% 
 
(of 1,615)
Sample origin is reported 1,615 100%
     Human origin 1,443 89%
     Animal origin 75 5%
     Food origin 92 6%
     Environmental origin 5 0%
Year of sampling is reported 1,615 100%
Sequencing method is reported 1,592 99%
Region of sampling is reported 
(province or higher resolution) 562 35%
Metadata with sequences of human 
origin 1,443
% 
 
(of 1,443)
Sequencing method is reported 1,420 98%
Patient sex is reported 1,349 93%
Patient year of birth is reported 1,332 92%
Year of sampling is reported 1,443 100%
Hospitalisation ‘yes/no’ is reported 391 27%
Symptoms are reported 293 20%
Mortality ‘yes/no’ reported 109 8%
Region of sampling is reported 
(province or higher resolution) 528 37%
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and Wales, Estonia, France, Germany, Ireland, Italy, the 
Netherlands, Portugal, Spain, Sweden, Switzerland 
and the US. With the exception of the one member 
from the US, all current experts in the network are from 
Europe. However, HEVnet aims to expand this collabo-
ration into a global network.
HEVnet has the potential to become an important 
resource for the scientific community working in the 
field of HEV. With the currently available sequences, 
patterns in circulating HEV subtypes can be analysed 
to identify and propose new reference viruses and to 
harmonise the classification and nomenclature of gen-
otypes and subtypes across countries. Future work will 
include the standardisation of sequencing protocols, 
an update of the reference set with tentative new sub-
types (focussed on genotype 3) and analyses of the 
submitted data.
Table 2 provides an overview of the metadata reported 
for 1,615 sequences submitted by 15 institutes in 
nine countries for the period April 2017–January 
2019. These sequences mainly originate from human 
cases (89%), and are rarely of animal (5%), food 
(6%) or environmental origin (0.3%). The number 
of sequences obtained from animals, food and the 
environment is not yet sufficient to investigate the HEV 
relationships across these disciplines, which is crucial 
for understanding the epidemiology of HEV. HEVnet 
encourages HEV experts from the veterinary, food and 
environmental sectors to join the network and support 
its growth by disseminating this invitation and con-
necting with projects of One Health initiatives, such as 
the One Health European Joint Programmes (https://
onehealthejp.eu/) and the Med-Vet-Net Association 
(http://mvnassociation.org/medvetnet/index.php).
Molecular epidemiological analyses focussing on 
human clinical data, including sequences from blood 
donors and patients with chronic HEV infection, might 
help to identify and better understand relationships 
between viruses, with regard to severity and associ-
ated risk factors. HEVnet allows collecting an array of 
clinically relevant parameters, such as duration and 
nature of symptoms, hospitalisation, comorbidity and 
treatment outcomes. However, as shown in  Table 2, 
the majority of submitted sequences of human ori-
gin contain only metadata on patient sex (93%), year 
of birth (92%) and year of sampling (100%). Far fewer 
sequences have metadata on the region of sampling 
(37%) or clinical information such as hospitalisation 
(27%), symptoms (20%) or mortality (8%). Improving 
the completeness of metadata in HEVnet could be 
accomplished if future studies link more variables of 
metadata to submitted sequences. For example, the 
Netherlands included a broad range of anonymised 
metadata when they submitted all available HEV 
sequences from a recent nationwide patient control 
study into risk factors of HEV [19]. Authors of future 
studies in which HEV sequences are collected together 
with metadata are encouraged to connect with HEVnet 
so they can benefit from the network collaboration 
by comparing their newly collected sequences to the 
worldwide repository. The availability of large datasets 
and full-length sequences will enable the refinement 
of current subgenotype classification and the identifi-
cation of new divergent subtypes in both humans and 
animals, over time.
Conclusion
Using a joint repository of molecular and epide-
miological data, HEVnet enables cross-sectoral and 
supranational collaborations to conduct molecular 
epidemiological investigations on HEV. A One Health 
approach is necessary to understand and mitigate HEV 
transmission via food, animals, substances of human 
origin and the environment. To strengthen the HEVnet 
database as an international One Health platform, it 
is necessary that more experts in the veterinary, food 
and environmental sectors join the network and sub-
mit their sequences with metadata. HEV experts across 
the world are invited to join the network by sending an 
email request (hevnet@rivm.nl) with a short explana-
tion of what they would like to contribute to the net-
work and the establishment of a worldwide reference 
set of HEV sequences.
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